S&P 5007,688.62+1.58%DOW53,356.12+3.03%NASDAQ25,736.51+1.44%BTC$80,787.00+5.07%ETH$2,431.65+7.47%GOLD$4,134.30+1.51%OIL$87.17-1.08%

NASDAQ · IART

Integra LifeSciences Holdings Corporation

Healthcare · Medical - Devices

$14.82

Up+$1.19 (+8.73%)

Updated Nov 5, 2026, 2:36 AM

SID Score

5.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap: 1.1B
P/E ratio: -2.18
Dividend yield: 0.00%
52-week range: $8.70 – $20.49
Volume: 1.17M
Avg. volume: 1.05M

Price performance · IART

IART price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 4, 2026

Last close: $14.82
Period change: +14.00%
Period low: $11.84
Period high: $14.82

Daily close

View OHLC price history

IART OHLC price history, latest 40 sessions
Date	Open	High	Low	Close	Volume
Nov 4, 2026	$13.97	$15.15	$13.84	$14.82	1.17M
Nov 3, 2026	$13.69	$13.79	$13.40	$13.63	1.69M
Nov 2, 2026	$12.98	$13.97	$12.98	$13.61	1.51M
Oct 30, 2026	$12.75	$12.86	$12.3338	$12.75	1.04M
Oct 29, 2026	$12.43	$13.005	$12.28	$12.83	1.19M
Oct 28, 2026	$11.98	$12.33	$11.93	$12.24	1.79M
Oct 27, 2026	$12.25	$12.25	$11.72	$11.99	1.43M
Oct 26, 2026	$12.05	$12.24	$12.00	$12.10	916.43K
Oct 23, 2026	$12.12	$12.396	$11.815	$11.91	1.21M
Oct 22, 2026	$11.69	$12.36	$11.66	$12.325	1.39M
Oct 21, 2026	$12.77	$13.745	$11.57	$11.84	2.02M
Oct 20, 2026	$13.51	$13.76	$13.27	$13.33	1.31M
Oct 19, 2026	$13.13	$13.49	$13.1113	$13.45	726.14K
Oct 16, 2026	$13.65	$13.83	$13.10	$13.21	831.02K
Oct 15, 2026	$13.38	$13.64	$13.285	$13.53	1.33M
Oct 14, 2026	$13.45	$13.79	$12.92	$13.175	1.11M
Oct 13, 2026	$14.05	$14.28	$13.66	$13.85	823.02K
Oct 12, 2026	$13.43	$14.03	$13.42	$13.98	893.71K
Oct 9, 2026	$13.38	$13.86	$13.23	$13.44	1.23M
Oct 8, 2026	$12.86	$13.435	$12.825	$13.41	1.46M
Oct 7, 2026	$13.19	$13.46	$12.98	$13.00	1.41M

Latest IART news

The latest Smart Investors Daily articles mentioning IART.

Featured By

Inc.

Nasdaq

Filter news

Filters are reflected in the page URL for sharing and back-button support.

IART news

3 matching articles.

Yahoo · Nov 4, 2026

Will Profit Return Change Integra LifeSciences Stock Narrative?

Integra LifeSciences reported third quarter 2026 sales of US$411.18 million and net income of US$14.85 million, with diluted earnings per share from continuing operations of US$0.19 compared with a diluted loss a year earlier. The company paired this return to profitability with fresh fourth quarter 2026 revenue guidance and plans to showcase key neurosurgery technologies at a major clinical meeting. Together these developments highlight both current operating traction and an effort to keep...

Yahoo · Nov 3, 2026

Integra LifeSciences Holdings (IART) Could Be 41% Undervalued On Third Quarter Profit Turnaround

Integra LifeSciences Holdings: Why Third Quarter Earnings Matter Now Integra LifeSciences Holdings (IART) has drawn fresh attention after third quarter 2026 results showed sales of US$411.18 million and a move from a prior net loss to US$14.85 million in profit. That earnings swing has landed in a period where Integra LifeSciences Holdings’ share price return has been volatile. The stock closed at US$13.61 after a 1 day share price return of 6.75% and a 7 day share price return of 12.48%, yet...

Yahoo · Oct 30, 2026

Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting

Aurora® Surgiscope ® System Aurora® Surgiscope ® System PRINCETON, N.J., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its participation in the 2026 Congress of Neurological Surgeons (CNS) Annual Meeting, taking place October 31-November 4 in Washington, D.C. At this year's meeting, Integra will showcase its comprehensive neurosurgery portfolio through interactive educational experiences, hands-o